RUN vs TRDA · P/E 6.0, rev $2.04B vs P/E 12, rev $210.8M
Sunrun Inc (RUN) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the RUN and TRDA stock pages for the full models.
Not investment advice.